Different fibrates have similar effects on dyslipidemia, but subtly differ in their impact on glucose metabolism, insulin resistance, intermittent claudication, and effects on microvascular complications of diabetes mellitus [177,184]. This evidence concerns the gene INS and metabolic syndrome.